Crossmark Global Holdings, Inc. Sarepta Therapeutics, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $5.61 Billion
- Q3 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 7,161 shares of SRPT stock, worth $893,621. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,161
Previous 6,167
16.12%
Holding current value
$893,621
Previous $975,000
8.31%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.1MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.12 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$781 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$544 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$533 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...